8Steinhubl SR,Tan WA,Foody JM,et al.Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting[J].JAMA,1999,281(9):806-810.
9Bennett CL,Davidson CJ,Raisch DW,et al.Thrombotic thrombocytope nic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention[J].Arch Intern Med,1999,159(21):2 524-2 528.
10Goa KL,Noble S.Eptifibatide:a review of its use in patients with acute coronary syndromes and/or undergoing percutancous coronary intervention[J].Drugs,1999,57(3):439-462.
二级参考文献63
1Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet, 1992, 340: 1111-1115.
2Anderson TJ,Meredith IT,Yeung AC,et al.The effect of cholesterol-lowering and antioxidant therapy on endothelium- dependent coronary vasomotion.N Engl J Med,1995,332:488-493.
3Jarvisalo MJ,Toikka JO,Vasankari T,et al. HMG CoA reductase inhibitors are related to improved systemic endothelial function in coronary artery disease. Atherosclerosis, 1999,147:237-242.
4Schwartz GG,Olsson AG,Ezekowitz MD,et al.MIRACL Study Investigators. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes :the MIRACL study: a randomized controlled trial. JAMA,2001,285:1711-1718.
5Arntz HR, Agrawal R, Wunderlich W,et al. Beneficial effects of pravastatin(+/-cholestiramine/ niacin)initiated immediately after a coronary event(the randomized Lipid-coronary artery disease[L-CAD]study).Am J Cardiol,2000,86:1293-1298.
6Nissen SE, Tuzcu EM,Schoenhagen P, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA,2004, 291:1071-1080.
7Cannon CP, Braunwald E, McCabe CH, et al. Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med, 2004, 350:1495-1504.
8Schiahbasi A, Andreotti F, De-Cristofaro R, et al.Prothrombotic response to coronary angioplasty in patients with unstable angina and raised C-reactive protein. J Thromb Thrombolysis,2002,14:131-138.
9Pasceri V, Willerson JT, Yeh EF, et al. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation, 2001,102:2165-2168.
10Torzewski J,Torzewki M,Bowyer DE,et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions or human coronary arteries.Arterioscler Thromb Vasc Biol, 1998,18 .. 1386-1392.
